Filing Flows › Lemaitre Vascular (LMAT) › Q4 2025
Lemaitre Vascular (LMAT) Q4 2025 earnings results (fourth quarter 2025)
10-K filed Feb 26, 2026
Lemaitre Vascular (LMAT) reported revenue of $64.5M for the fourth quarter 2025 (Q4 2025), +16% from a year earlier and +6% from the quarter before. Operating margin was 29.2%, net earnings $15.6M (24.2% of revenue).
Lemaitre Vascular, Q4 2025: revenue $64.5M (+16% year over year), operating margin 29.2%, net earnings $15.6M, operating cash flow $23.2M. The chart follows the revenue to costs, profit and cash.
| Q4 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $64.5M | +6% | +16% |
| Gross profit | $46.2M | +0.5% | +20% |
| Operating profit | $18.8M | -7% | +47% |
| Net earnings | $15.6M | -10% | +39% |
| Operating cash flow | $23.2M | -19% | +53% |
| Free cash flow | $21.4M | -19% | +63% |
What changed
Revenue was $64.5M in Q4 2025, up 16% year over year and up 6% from the previous quarter.
Gross margin was 71.7%, up 2.4 points from a year earlier. Operating profit was $18.8M, a 29.2% margin (up 6.1 points year over year). Of the extra revenue versus a year earlier, 68% reached operating profit, above the 23% margin then. Operating expenses grew 6% against revenue growth of 16%. Net earnings were $15.6M, up 39% year over year. The effective tax rate was 23.2%.
Operating cash flow was $23.2M (up 53% year over year), 149% of net earnings. Non-cash charges added back $2.6M of depreciation and amortization and $2.1M of share-based compensation. Working capital and other items added $2.9M. Capital expenditures of $1.8M left free cash flow of $21.4M.
Questions
What was Lemaitre Vascular's revenue in the fourth quarter 2025?
Lemaitre Vascular (LMAT) reported revenue of $64.5M for the fourth quarter 2025 (Q4 2025), +16% from a year earlier and +6% from the quarter before.
Was Lemaitre Vascular profitable in the fourth quarter 2025?
Operating profit was $18.8M (29.2% of revenue) and net earnings $15.6M.
Source: Lemaitre Vascular 10-K on SEC EDGAR.